Fda approves spinraza nusinersen december 2016?

When did the FDA approve Spinraza (nusinersen)?

The FDA approved Spinraza (nusinersen) in December 2016.[1]

What Spinraza was approved for at launch

Spinraza was approved for the treatment of spinal muscular atrophy (SMA). [1]

Was it the first FDA approval for nusinersen?

Yes—this December 2016 FDA approval marked the original approval of nusinersen (Spinraza) by the FDA.[1]

Source

[1] https://www.drugpatentwatch.com/p/spinraza